HALEY SWANSON: Open Payments
NPI 1972254118 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 53 payments from 16 companies in 2025. Trend: 2023 $1,390 · 2024 $1,272 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $154 |
| GlaxoSmithKline, LLC. | 4 | $115 |
| ABBVIE INC. | 6 | $107 |
| Lilly USA, LLC | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| Novo Nordisk Inc | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| Lundbeck LLC | 3 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Abbott Laboratories | 2 | $43 |
Products named: REXULTI, TRELEGY ELLIPTA, NURTEC ODT, MOUNJARO, UBRELVY, JARDIANCE, PREVNAR 20, GEMTESA.
Industry payments across VA — which companies pay providers there.
